Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction.
about
Proteomic detection of cancer in asbestosis patients using SELDI-TOF discovered serum protein biomarkersSELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium diseaseSerum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assaysEvaluating the effects of preanalytical variables on the stability of the human plasma proteomeMass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations.Progress and challenges in screening for early detection of ovarian cancer.Differential exoprotease activities confer tumor-specific serum peptidome patternsHuman body fluid proteome analysis.Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations.Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning.Approaching clinical proteomics: current state and future fields of application in fluid proteomics.Assessment of Protein Stability in Cerebrospinal Fluid Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Protein Profiling.Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.Discovery of serum protein biomarkers in rheumatoid arthritis using MALDI-TOF-MS combined with magnetic beads.MALDI mass spectrometric imaging of cardiac tissue following myocardial infarction in a rat coronary artery ligation modelFunctional protease profiling for diagnosis of malignant disease.A survey of membrane proteins in human serumPermeation through phospholipid bilayers, skin-cell penetration, plasma stability, and CD spectra of α- and β-oligoproline derivatives.Proteomic identification of biomarkers of vascular injury.Comprehensive quantitative analysis of ovarian and breast cancer tumor peptidomes.Clinical proteomics: present and future prospects.Multifunctional core-shell nanoparticles: discovery of previously invisible biomarkers.Phenotype-Driven Plasma Biobanking Strategies and MethodsMass spectrometry-based proteomics for translational research: a technical overview.Global stability of plasma proteomes for mass spectrometry-based analyses.Proteomics and heart disease: identifying biomarkers of clinical utility.Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics.Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears.Identification of clinical biomarkers for pre-analytical quality control of blood samples.Proteomics in atherothrombosis: a future perspective.Plasma/serum proteomics: pre-analytical issues.Pre-analytical stability of the plasma proteomes based on the storage temperature.Genetic dissection of platelet function in health and disease using systems biology.Mass spectrometry-based proteomic profiling of lung cancer.Proteomic Biomarkers of Atherosclerosis.Analysis of human plasma proteins: a focus on sample collection and separation using free-flow electrophoresis.The application of proteomics technology to thrombosis research: the identification of potential therapeutic targets in cardiovascular disease.Endogenous plasma Peptide detection and identification in the rat by a combination of fractionation methods and mass spectrometry.Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
P2860
Q23910532-B7B293ED-0436-42E8-B263-AA2D06BBAFB2Q28389150-F082C0F1-5139-4320-8DC4-BDC808D3B906Q28743469-55ECF2B0-AAE7-426A-AB53-53CAEF80364CQ30372676-E8BF91FC-9DE3-4C93-A797-11297D695A25Q30751781-171E9D8D-D820-40E4-ADC5-C7EC549C5FBDQ31041170-F7A69604-234E-4AEE-8725-C6848AD2DD39Q33230965-FF0D4171-CE25-4672-B0C0-EC878134D126Q33262623-313C366E-1CD6-41D9-8F5D-E8693C5EED6DQ33301109-B46E2619-8B3E-470C-BC9F-EE378EE83800Q33304365-3D70C07C-22A0-4545-B9DE-A560465C3ED7Q33312689-A3B1CA0E-9677-4FAF-B84F-AB39A0BB7A36Q33467523-6969ECA2-11B4-44FF-A1D1-A266143499D8Q33536646-4E132A2A-6A0C-4C25-8FA1-1EC9B03050FEQ33877162-3075B42F-96A4-4851-B30D-7F72C270FA73Q34020523-D555760E-E0F2-4C00-BC3D-B6773E2E79CBQ34091649-AFF06382-776E-4A07-9250-C769C145E9CCQ34116114-E78E63F2-9DDD-4930-BA80-5C5A5356676FQ34254384-BD7C97F8-24F8-44D7-B96B-B7E3393A1171Q34557817-F2A89615-1009-412B-AA48-781BFF5929A6Q34667425-120205CE-EA6A-4244-838A-9A9771046968Q34855337-3A86FD8C-62A2-4DE3-BC1F-EFE14AF429C5Q35053674-EDE8F177-CF06-4770-93C0-7AFB8B7DC115Q35571271-30143F89-5684-4371-BC2E-4521DFE804AAQ35674060-1D446CCF-0DBC-4A9A-9BD5-2CFC297174D6Q35855485-698FEC52-3FA7-493F-B209-B1EB3F13D474Q36208968-74E9E33C-F24C-47DC-8F1D-27BEA1954381Q36445586-DB9D45E4-BB23-4F00-B1EC-219E9BBAA5F7Q36562084-DBFD4DCF-EFA8-4966-B0B7-36F7406039CBQ36640047-35E8A437-4BA4-49C0-94DF-A12D270E91B5Q36776513-BA0DD8A1-338A-4978-B078-5A0D2E5411EDQ36787244-529FEEAC-4B56-4D27-BBA0-0567A3C07C22Q36841871-58428A63-35E2-45C6-8626-4BCE1F55E2B0Q36858663-91747A70-1398-47F6-B41C-00D534266294Q37156517-7CACA4E8-5407-410E-9C52-857A650FCF97Q37171914-75CC25DB-7928-4FCF-9188-9A7737761DDFQ37207340-6301B7B5-DC7B-4DDE-8580-D409344B147DQ37257661-8D412FB8-A595-4857-9D63-2550C04261E7Q37262970-15139EB8-63EA-420F-908C-85CE1602EF1FQ37280925-10C3E40F-1ADF-4587-940E-4D15ABD1542FQ37484011-47B86A3C-D681-426D-90F3-B86F956DD082
P2860
Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Processing of serum proteins u ...... ting of myocardial infarction.
@ast
Processing of serum proteins u ...... ting of myocardial infarction.
@en
type
label
Processing of serum proteins u ...... ting of myocardial infarction.
@ast
Processing of serum proteins u ...... ting of myocardial infarction.
@en
prefLabel
Processing of serum proteins u ...... ting of myocardial infarction.
@ast
Processing of serum proteins u ...... ting of myocardial infarction.
@en
P2093
P356
P1476
Processing of serum proteins u ...... ting of myocardial infarction.
@en
P2093
Chris Smith
Eric Stanton
George Jackowski
Inga Kireeva
Jason Yantha
John Marshall
Kellie Jacks
Miyoko Takahashi
Peter Kupchak
Rulin Zhang
P304
P356
10.1021/PR030003L
P577
2003-07-01T00:00:00Z